Brenda Hamilton, NYSE, Nasdaq, Securities and Going Public Lawyer
Profile:
Brenda Hamilton is the Founder & Managing Partner of Hamilton & Associates Law Group, P.A., and the principal of the SecuritiesLawyer101.com legal resource brand. Hamilton & Associates Law Group, P.A. +3 Hamilton & Associates Law Group, P.A. +3 Justia Lawyer Directory +3Practice Focus She specializes in corporate, securities, business, and transactional law, advising both domestic and international clients on going-public transactions, regulatory compliance, disclosures, capital raising, and enforcement matters. Justia Lawyer Directory +3 Hamilton & Associates Law Group, P.A. +3 Hamilton & Associates Law Group, P.A. +3Her work spans IPOs, direct public offerings, exchange listings (NASDAQ, NYSE, OTC), corporate restructurings, and forensic securities counsel. Hamilton & Associates Law Group, P.A. +3 Hamilton & Associates Law Group, P.A. +3 Hamilton & Associates Law Group, P.A. +3Experience & Notable EngagementsShe has served as U.S. Outside General Counsel to a global, NYSE-listed conglomerate with revenues in the hundreds of millions and operations in multiple countries. Hamilton & Associates Law Group, P.A.She has represented issuers in SEC registration, reporting, and compliance—from small offerings (< $1 million) to deals over $300 million. Hamilton & Associates Law Group, P.A. +2 Hamilton & Associates Law Group, P.A. +2She has taken on regulatory, forensic, and securities enforcement matters, including matters involving trading schemes, sanctions, and securities fraud. Hamilton & Associates Law Group, P.A. +2 Hamilton & Associates Law Group, P.A. +2She has acted as an Independent Compliance Consultant in an SEC administrative matter, advising a registered transfer agent on implementing reforms. Hamilton & Associates Law Group, P.A.Media & Thought Leadership Brenda Hamilton is frequently cited in major media outlets for her securities law expertise, including Forbes, Bloomberg, Business Insider, and South Florida Business Journal. Hamilton & Associates Law Group, P.A.Her blog, SecuritiesLawyer101, regularly covers topics in capital markets, going public processes, NYSE, Nasdaq abd OTC Markets, and securities regulations.
Posts by Brenda Hamilton, NYSE, Nasdaq, Securities and Going Public Lawyer:
- Diverse Financial and Principals Charged with Fraud
- SEC Obtains Asset Freeze Over Joseph Gabalon
- Rebecca Norton Insider Trading Settlement Approved
- Brown Investment Advisors Charged with Operating Three Offering Frauds
- John Williams Charged with Conducting Misappropriation Scheme and Offering Fraud
- Court Reaches Final Judgement of Disgorgement and Civil Penalties Against Stock Fraudsters
- Why Operation Shell Expel Gets an F
- Settlement Reached in Vladimir Eydelman Insider Trading Case
- Darren Ofsink Indicted – Securities Lawyers Gone Wild
- Default Judgment Grants Full Relief Against Premiere Power and Its Chairman in Offering Fraud
- Schedule 13D and 13G Filing Requirements Securities Lawyer 101 Q&A
- Keeping A Close Watch On Equity Crowdfunding
- What Is Wrong With Buying a Shell To Go Public?
- Donald Lester and His Private Firm Charged with Fraud
- Hedge Fund Manager Lonny Bernath Charged with Fraud
- SEC Obtains Summary Judgment Against Andrew Farmer in Pump-And-Dump Scheme
- SEC Charges Nicolas Zanen and His Friend with Insider Trading
- Equity Crowdfunding Approved – Going Public Attorney
- SEC Issues Trading Suspension of Locan & American Power Corp
- What Disclosure Is Required By Rule 15c2-11?
- SEC Wins Summary Judgment Against Allen Smith
- SEC Addresses Equity Crowdfunding – Going Public Attorney
- Court Enters Default Judgment Against James Erwin and Malom Group
- SEC Obtains Final Judgments Against Operators of a Ponzi Scheme
- SEC Charges Oscar Wu With Settled Insider Trading
- Former Executives of OCZ Technology Group Charged with Fraud
- SEC Charges Steve Chen With Fraud and Imposes Asset Freeze
- James Quay Found Guilty for Perjury and Fraud
- The SEC Charges Arizona Players with Embezzlement
- Final Judgement Entered Against Amyot And Spencer Pharmaceutical